Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in routine care: 2-year outcomes and predictors
Cecilie Heegaard Brahe, Simon Krabbe, Mikkel Østergaard, Lykke Ørnbjerg, Daniel Glinatsi, Henrik Røgind, Hanne S. Jensen, Annette Hansen, Jesper Nørregaard, Søren Jacobsen, Lene Terslev, Tuan K. Huynh, Dorte V. Jensen, Natalia Manilo, Karsten Asmussen, Per Brown Frandsen, Mikael Boesen, Zoreh Rastiemadabadi, Lone Morsel Carlsen, Jakob M. MøllerNiels S. Krogh, Merete Lund Hetland
Dive into the research topics of 'Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in routine care: 2-year outcomes and predictors'. Together they form a unique fingerprint.